Part D insurers eye the bottom line

Part D insurers eye the bottom line

Lipton
Lipton

Helene Levens Lipton, PhD, UCSF School of Pharmacy faculty member and health policy expert, comments that insurers will remain in the Medicare Part D marketplace as long as they benefit.

Full story

Medicare Drug Plan is Prescribing Profits, Business Gains Could Diminish as Program Evolves 

More

[Pharmacists Clarify the Medicare Part D Fog] [link defunct]